SMARCA4 and renal fibrosis: Collectively, these data indicated that BRG1 exerted fibrotic action mainly via inducing tubular senescence, suggesting that targeting blockage of BRG1 may be a potential therapeutic strategy to improve cellular senescence and renal fibrosis in CKD.